|
|||||
|
|
| Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma | |
| 引用本文： | Bennouna J,Bompas E,Neidhardt EM,Rolland F,Philip I,Galéa C,Salot S,Saiagh S,Audrain M,Rimbert M,Lafaye-de Micheaux S,Tiollier J,Négrier S.Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma[J].Cancer Immunology, Immunotherapy,2008,57(11):1599-1609. |
| 作者姓名： | Bennouna J Bompas E Neidhardt EM Rolland F Philip I Galéa C Salot S Saiagh S Audrain M Rimbert M Lafaye-de Micheaux S Tiollier J Négrier S |
| 摘 要： | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |